(Q38442917)

3 September 2017

title

Concordance of the hormone receptors and correlation of HER-2/neu overexpression of the metachronous cancers of contralateral breasts (English)

1 reference

3 September 2017

1 reference

Azadeh Stark

1

1 reference

3 September 2017

Mei Lu

series ordinal

2

1 reference

3 September 2017

Patricia Mackowiak

series ordinal

3

1 reference

3 September 2017

Michael Linden

series ordinal

4

1 reference

3 September 2017

publication date

1 May 2005

1 reference

3 September 2017

1 reference

3 September 2017

volume

11

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

183-187

1 reference

Evolving perspectives in contralateral breast cancer

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21579.X

Epidemiologic and molecular risk factors for contralateral breast cancer among young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21579.X

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21579.X

Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21579.X

The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21579.X

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21579.X

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21579.X

Factors associated with repeat adherence to breast cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21579.X

Development and validation of a sensitive immunohistochemical oestrogen receptor assay for use on archival breast cancer tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21579.X

Molecular mechanisms of antiestrogen action in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21579.X

Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2005.21579.X

10.1111/J.1075-122X.2005.21579.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference